Percutaneous vertebroplasty in metastatic vertebral fracture: A retrospective cross-sectional study

Introduction: Metastatic vertebral fractures (VF) commonly cause severe disabling pain in cancer patients. VFs are common among elderly patients and account for approximately 1.5 million per year in the general population. Objective: Bone metastasis, which is a second major cause of pathologic fract...

Full description

Saved in:
Bibliographic Details
Published inIndian Journal of Pain Vol. 36; no. 4; pp. 40 - 45
Main Authors Rastogi, Shivani, Agarwal, Anurag, Litin, Yasum, Singh, Neha, Patel, Hitesh
Format Journal Article
LanguageEnglish
Published Wolters Kluwer India Pvt. Ltd 01.12.2022
Medknow Publications and Media Pvt. Ltd
Wolters Kluwer Medknow Publications
Subjects
bone cement
cancer
Care and treatment
Fractures
Metastasis
Orthopedic surgery
Pain
percutaneous vertebroplasty
vertebral metastasis
visual analog scale
Visual Analog Scale
Bone cement
cancer
percutaneous vertebroplasty
vertebral metastasis
Online AccessGet full text

Cover

More Information
Summary:Introduction: Metastatic vertebral fractures (VF) commonly cause severe disabling pain in cancer patients. VFs are common among elderly patients and account for approximately 1.5 million per year in the general population. Objective: Bone metastasis, which is a second major cause of pathologic fracture, may lead to severe intolerable pain, life-threatening hypercalcemia, spinal cord compression, and immobility. The purpose of this study was to evaluate pain relief and improvement in quality of life (QOL) in patients with metastatic VF undergoing percutaneous vertebroplasty (PVP). Methods: Ten cancer patients having metastatic VF underwent PVP from July 2018 to August 2020. All demographic data, procedures, improvement in pain, and analgesic requirements of patients were taken from a computer data system and telephonic follow-up. Results: Majority of patients were suffering from carcinoma lung followed by carcinoma pancreas. The mean ± standard deviation of Visual Analog Scale preoperatively was 8.8 ± 1.35, reduced to 2.14 ± 2.11 at 6 months postoperatively, suggesting significant pain reduction. Eight patients had reduction in analgesic requirements and two did not require any analgesics postoperatively. During the entire follow-up, there was no delayed complication. Conclusion: PVP is an effective, safe, and minimally invasive procedure for treating painful metastatic vertebral compression fracture refractory to conservative treatments. It provides a marked reduction of pain, maintains mechanical stability of the vertebrae, and improves QOL.
ISSN:0970-5333
DOI:10.4103/ijpn.ijpn_103_22